Opportunities for collaboration between pharmacists and clinical pharmacologists to support medicines optimisation in the UK
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13966
Abstract: Medicines optimisation is a clinician‐driven, person‐centred ongoing process. Pharmacists and clinical pharmacologists have medicines‐related expertise to deliver medication review which optimises clinical and cost‐effective use of medication, aligned with patient preferences, contributing to improved health… read more here.
Keywords: opportunities collaboration; clinical pharmacologists; medicines optimisation; pharmacists clinical ... See more keywords
SP11 Family integrated care: a way forward for medicines optimisation on the special care baby unit
Sign Up to like & getrecommendations! Published in 2018 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-314584.11
Abstract: Introduction Family Integrated Care (FIC) is a new model of care within the neonatal unit that aims to empower parents to take a more active role in caring for their newborn child. FIC has been… read more here.
Keywords: family integrated; unit; medicines optimisation; integrated care ... See more keywords
Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model
Sign Up to like & getrecommendations! Published in 2018 at "Open Heart"
DOI: 10.1136/openhrt-2018-000921
Abstract: Background Inadequate medicines optimisation and adherence are significant problems among patients taking secondary prevention medications following myocardial infarction (MI). A novel joint consultant cardiology pharmacist and cardiologist medicines optimisation clinic was initiated for patients recently… read more here.
Keywords: cardiologist; cardiology; medicines optimisation; joint consultant ... See more keywords
Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Open Heart"
DOI: 10.1136/openhrt-2021-001931
Abstract: Background Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is) are an important but underutilised option to help optimise lipid management. We developed a new service to improve patient access to these medicines in line with National… read more here.
Keywords: pcsk9i therapy; optimisation; centralised multidisciplinary; optimisation clinic ... See more keywords
Nobody ever questions—Polypharmacy in care homes: A mixed methods evaluation of a multidisciplinary medicines optimisation initiative
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0244519
Abstract: Background Nurse-led monitoring of patients for signs and symptoms associated with documented ‘undesirable effects’ of medicines has potential to prevent avoidable harm, and optimise prescribing. Intervention The Adverse Drug Reaction Profile for polypharmacy (ADRe-p) identifies… read more here.
Keywords: nobody ever; care homes; medicines optimisation; evaluation ... See more keywords
An Observational Cohort Study to Evaluate the Impact of a Tailored Medicines Optimisation Service on Medication Use, Accident and Emergency Department Visits, and Admissions Among Patients Identified with Medication Support Needs in Secondary Care
Sign Up to like & getrecommendations! Published in 2022 at "Patient preference and adherence"
DOI: 10.2147/ppa.s376686
Abstract: Purpose Quantifying the impact of pharmacy interventions, such as tailored medicines optimisation, can be challenging owing to the sometimes-indirect nature of their effect on patient outcomes such A&E (Accident & Emergency) attendance, hospital admission and… read more here.
Keywords: medication; impact; support; study ... See more keywords